Denosumab, osteoporosis, and prevention of fractures

N Engl J Med. 2009 Nov 26;361(22):2189-90; author reply 2190-1.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / economics
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Bone Density Conservation Agents / economics
  • Bone Density Conservation Agents / therapeutic use*
  • Denosumab
  • Drug Costs
  • Female
  • Fractures, Bone / prevention & control
  • Humans
  • Osteoporosis, Postmenopausal / drug therapy*
  • RANK Ligand / economics
  • RANK Ligand / therapeutic use*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bone Density Conservation Agents
  • RANK Ligand
  • Denosumab